Michael Fons

Corporate Officer/Principal en University of Texas Medical Branch .

64 años

Health Technology

Consumer Services

Cargos activos de Michael Fons

Empresas	Cargo	Inicio	Fin
University of Texas Medical Branch	Corporate Officer/Principal	-	-

Empresas	Cargo	Inicio	Fin
Vical, Inc. Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.	Corporate Officer/Principal	01/01/2004	01/01/2004
INOVIO PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/06/2004	-

Internacional

Estados Unidos

Operativa

Corporate Officer/Principal

Sectorial

Health Technology	3
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	1
INOVIO PHARMACEUTICALS, INC.	Health Technology

Empresas privadas	1
Vical, Inc. Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.	Health Technology

Empresas privadas

Health Technology